ATE249821T1 - Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut - Google Patents

Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut

Info

Publication number
ATE249821T1
ATE249821T1 AT99930683T AT99930683T ATE249821T1 AT E249821 T1 ATE249821 T1 AT E249821T1 AT 99930683 T AT99930683 T AT 99930683T AT 99930683 T AT99930683 T AT 99930683T AT E249821 T1 ATE249821 T1 AT E249821T1
Authority
AT
Austria
Prior art keywords
mucosa
reducing
radiation therapy
harmful effects
animal skin
Prior art date
Application number
AT99930683T
Other languages
English (en)
Inventor
Deborah J Davenport
Kathy L Gross
Gregory K Ogilvie
Michael S Hand
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of ATE249821T1 publication Critical patent/ATE249821T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT99930683T 1998-06-29 1999-06-24 Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut ATE249821T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,295 US6015798A (en) 1995-10-10 1998-06-29 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
PCT/US1999/014344 WO2000000189A1 (en) 1998-06-29 1999-06-24 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Publications (1)

Publication Number Publication Date
ATE249821T1 true ATE249821T1 (de) 2003-10-15

Family

ID=22310643

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99930683T ATE249821T1 (de) 1998-06-29 1999-06-24 Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut

Country Status (17)

Country Link
US (1) US6015798A (de)
EP (1) EP1091734B1 (de)
JP (2) JP4860814B2 (de)
AR (1) AR019728A1 (de)
AT (1) ATE249821T1 (de)
AU (1) AU761266B2 (de)
BR (1) BR9911663A (de)
CA (1) CA2336628C (de)
DE (1) DE69911409T2 (de)
DK (1) DK1091734T3 (de)
ES (1) ES2207951T3 (de)
MX (1) MXPA01000152A (de)
NO (1) NO329910B1 (de)
NZ (1) NZ508766A (de)
TR (1) TR200100457T2 (de)
WO (1) WO2000000189A1 (de)
ZA (1) ZA200007650B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
ATE512594T1 (de) * 1999-09-09 2011-07-15 Nestle Sa Verbesserung des zustandes älterer haustiere
ES2284644T3 (es) * 2000-05-01 2007-11-16 The Iams Company Composicion alimenticia para animales de compañia para reducir la respuesta inflamatoria en gatos.
AU2001265273B2 (en) 2000-06-01 2006-11-23 Jbs United, Inc. Animal food and method
EP1350435B1 (de) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren
US8841344B2 (en) * 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US6899904B2 (en) * 2002-11-14 2005-05-31 The Meow Mix Company Pet food compositions having electrostatically charged ingredient
US6841179B2 (en) 2002-11-14 2005-01-11 The Meow Mix Company Pet food compositions comprising electrostatically charged gelatin
GB2414916A (en) * 2002-12-23 2005-12-14 Mars Uk Ltd Food for gastrointestinal health
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
ATE402695T1 (de) * 2003-08-11 2008-08-15 Hills Pet Nutrition Inc Omega-3-fettsäuren zur behandlung von osteoarthritis bei hunden
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
EP2324828A1 (de) * 2003-08-18 2011-05-25 BTG International Limited Behandlung neurodegenerativer Erkrankungen
ES2525729T3 (es) 2003-11-25 2014-12-29 Virginia Tech Intellectual Properties, Inc. Composición para consumo animal para su uso en la reducción de la actividad MAP cinasa
US20070031534A1 (en) * 2004-02-27 2007-02-08 Hajime Tsujimoto Pet food for reducing food allergy reactions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
CN101150962A (zh) 2004-12-30 2008-03-26 希尔氏宠物营养品公司 提高幼年动物生活质量的方法
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
US8729133B2 (en) * 2006-02-28 2014-05-20 Cornell University Method for treating cancer
ES2748136T3 (es) 2007-10-15 2020-03-13 United Animal Health Inc Método para aumentar el rendimiento de las crías
WO2009070589A1 (en) * 2007-11-30 2009-06-04 Jbs United, Inc. Method and composition for treating pulmonary hemorrhage
JP6001184B2 (ja) * 2012-11-15 2016-10-05 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 食餌のミネラル制限を介したヘアボール制御
CA3052047A1 (en) 2017-02-13 2018-08-16 Wintermute Biomedical, Inc. Anti-pathogenic therapeutic compositions
MX2021003810A (es) 2018-10-01 2021-07-06 Wintermute Biomedical Inc Composiciones terapeuticas.
AU2019478729B2 (en) * 2019-12-19 2024-08-29 Hill's Pet Nutrition, Inc. Reagents, kits and methods for assessing and reducing risk of developing canine hypothyroidism and other autoimmune conditions
AU2019479288B2 (en) 2019-12-19 2024-04-18 Hill's Pet Nutrition, Inc. Compositions comprising a particular ratio of insoluble to soluble fibre for use in the treatment of e.g. anxiety
WO2022087203A1 (en) * 2020-10-21 2022-04-28 Hill's Pet Nutrition, Inc. Pet food compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
DE68904874T2 (de) * 1988-10-31 1993-07-15 Sandoz Nutrition Ltd Organische verbindungen.
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
US5776913A (en) * 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Also Published As

Publication number Publication date
AU761266B2 (en) 2003-05-29
NO20006575L (no) 2001-02-28
NO329910B1 (no) 2011-01-24
ZA200007650B (en) 2002-08-28
TR200100457T2 (tr) 2001-08-21
CA2336628C (en) 2009-03-24
DK1091734T3 (da) 2004-01-26
JP5704791B2 (ja) 2015-04-22
NZ508766A (en) 2003-05-30
AU4716799A (en) 2000-01-17
NO20006575D0 (no) 2000-12-21
DE69911409T2 (de) 2004-07-08
EP1091734B1 (de) 2003-09-17
MXPA01000152A (es) 2002-10-17
AR019728A1 (es) 2002-03-13
JP2002519320A (ja) 2002-07-02
WO2000000189A1 (en) 2000-01-06
EP1091734A1 (de) 2001-04-18
JP2009035533A (ja) 2009-02-19
US6015798A (en) 2000-01-18
ES2207951T3 (es) 2004-06-01
CA2336628A1 (en) 2000-01-06
DE69911409D1 (de) 2003-10-23
JP4860814B2 (ja) 2012-01-25
BR9911663A (pt) 2005-12-20

Similar Documents

Publication Publication Date Title
DE69911409D1 (de) Verfahren zur verringerung der schädlichen wirkungen von bestrahlungstherapie auf tierische haut und schleimhaut
EP0740566A4 (de) Verfahren und vorrichtung zur gleichmässigen strahlenbehandlung von herzlumen
ATE397868T1 (de) Verfahren zur verbesserung der haut und des pelzes von haustieren
DE69938870D1 (de) Verfahren zur verbesserten bilderzeugung und photodynamischen therapie
DE69529627D1 (de) Verfahren und vorrichtung zur interstitiellen bestrahlung der prostata
FI963696L (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69926348D1 (de) System zur elektromagnetischen bestrahlung der haut
DE69813919D1 (de) Flüssigkeitgekülter Ablationskatheter und Herstellungsmethode
DE59306276D1 (de) Verfahren und anordnung zur therapie von gewebe mit ultraschall
DE59510184D1 (de) Einrichtung und verfahren zur hautuntersuchung
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
ATE331522T1 (de) Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum
DE69828620D1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung der chronologischer alterung der menschliches haut
ATE347360T1 (de) Verfahren zur induktion von krebszellentod und tumorregression
DE10084417T1 (de) Verfahren und Apparat zur therapeutischen Laserbehandlung
DE69227103D1 (de) Implantierbare gewebegrundlage und verfahren zur reduzierung der immunogenität
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE59810847D1 (de) Verfahren zur form- und volumengebung von humanhaaren
DE69734751D1 (de) Bestrahlungsbehandlungsvorrichtung und Verfahren
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
DE60038663D1 (de) Thyristoren und verfahren zur herstellung
DE69434268D1 (de) VDMOS-Leistungsbauteil und Verfahren zur Herstellung desselben
FI951060L (fi) Formulaatioita ja hoitomenetelmiä

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties